Alice Morigi

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma.

Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma.

Journal: European journal of haematology

Published: July 09, 2024

Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report.

Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report.

Journal: Chemotherapy

Published: July 25, 2022

Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series.

Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series.

Journal: Tumori

Published: April 20, 2022

BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience.

BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience.

Journal: Journal of cancer research and clinical oncology

Published: January 17, 2022

Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience.

Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience.

Journal: Journal of clinical medicine

Published: October 12, 2021

Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.

Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.

Journal: Hematological oncology

Published: September 08, 2021

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience.

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience.

Journal: Cancers

Published: July 16, 2021

The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience.

The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience.

Journal: American journal of hematology

Published: May 05, 2021

Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation.

Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 16, 2021

Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma.

Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma.

Journal: Leukemia & lymphoma

Published: December 04, 2020

Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience.

Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience.

Journal: Hematological oncology

Published: July 06, 2020

Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients.

Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients.

Journal: Annals of hematology

Published: June 10, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026